Annual Total Liabilities
$1.78 B
-$362.63 M-16.96%
31 December 2023
Summary:
IDEXX Laboratories annual total liabilities is currently $1.78 billion, with the most recent change of -$362.63 million (-16.96%) on 31 December 2023. During the last 3 years, it has risen by +$113.63 million (+6.84%). IDXX annual total liabilities is now -16.96% below its all-time high of $2.14 billion, reached on 31 December 2022.IDXX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$1.73 B
-$101.90 M-5.55%
30 September 2024
Summary:
IDEXX Laboratories quarterly total liabilities is currently $1.73 billion, with the most recent change of -$101.90 million (-5.55%) on 30 September 2024. Over the past year, it has dropped by -$56.28 million (-3.15%). IDXX quarterly total liabilities is now -19.93% below its all-time high of $2.16 billion, reached on 30 September 2022.IDXX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -17.0% | -3.1% |
3 y3 years | +6.8% | +6.3% |
5 y5 years | +14.8% | +11.9% |
IDXX Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -17.0% | +6.8% | -19.9% | +6.3% |
5 y | 5 years | -17.0% | +14.8% | -19.9% | +11.9% |
alltime | all time | -17.0% | >+9999.0% | -19.9% | >+9999.0% |
IDEXX Laboratories Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.73 B(-5.6%) |
June 2024 | - | $1.83 B(+2.8%) |
Mar 2024 | - | $1.78 B(+0.5%) |
Dec 2023 | $1.78 B(-17.0%) | $1.78 B(-0.8%) |
Sept 2023 | - | $1.79 B(+0.7%) |
June 2023 | - | $1.78 B(-9.7%) |
Mar 2023 | - | $1.97 B(-8.0%) |
Dec 2022 | $2.14 B(+22.4%) | $2.14 B(-1.2%) |
Sept 2022 | - | $2.16 B(+0.6%) |
June 2022 | - | $2.15 B(+10.1%) |
Mar 2022 | - | $1.95 B(+11.8%) |
Dec 2021 | $1.75 B(+5.1%) | $1.75 B(+7.2%) |
Sept 2021 | - | $1.63 B(-2.0%) |
June 2021 | - | $1.66 B(+2.5%) |
Mar 2021 | - | $1.62 B(-2.3%) |
Dec 2020 | $1.66 B(+0.4%) | $1.66 B(+3.5%) |
Sept 2020 | - | $1.61 B(-4.8%) |
June 2020 | - | $1.69 B(-5.1%) |
Mar 2020 | - | $1.78 B(+7.5%) |
Dec 2019 | $1.65 B(+7.0%) | $1.65 B(+6.8%) |
Sept 2019 | - | $1.55 B(-0.3%) |
June 2019 | - | $1.55 B(-4.7%) |
Mar 2019 | - | $1.63 B(+5.3%) |
Dec 2018 | $1.55 B(-12.5%) | $1.55 B(+0.0%) |
Sept 2018 | - | $1.55 B(-1.0%) |
June 2018 | - | $1.56 B(+2.8%) |
Mar 2018 | - | $1.52 B(-14.1%) |
Dec 2017 | $1.77 B(+7.8%) | $1.77 B(+2.9%) |
Sept 2017 | - | $1.72 B(-0.3%) |
June 2017 | - | $1.72 B(+4.7%) |
Mar 2017 | - | $1.65 B(+0.4%) |
Dec 2016 | $1.64 B(+5.1%) | $1.64 B(+13.4%) |
Sept 2016 | - | $1.45 B(-3.5%) |
June 2016 | - | $1.50 B(-3.5%) |
Mar 2016 | - | $1.55 B(-0.4%) |
Dec 2015 | $1.56 B(+23.1%) | $1.56 B(+2.8%) |
Sept 2015 | - | $1.52 B(+3.2%) |
June 2015 | - | $1.47 B(+5.1%) |
Mar 2015 | - | $1.40 B(+10.3%) |
Dec 2014 | $1.27 B(+77.8%) | $1.27 B(+19.4%) |
Sept 2014 | - | $1.06 B(+27.8%) |
June 2014 | - | $830.26 M(+10.7%) |
Mar 2014 | - | $750.07 M(+5.3%) |
Dec 2013 | $712.30 M(+52.4%) | $712.30 M(+7.9%) |
Sept 2013 | - | $660.34 M(+7.5%) |
June 2013 | - | $614.48 M(+22.6%) |
Mar 2013 | - | $501.34 M(+7.3%) |
Dec 2012 | $467.35 M(-4.9%) | $467.35 M(-1.8%) |
Sept 2012 | - | $475.82 M(-0.3%) |
June 2012 | - | $477.38 M(-3.4%) |
Mar 2012 | - | $494.22 M(+0.6%) |
Dec 2011 | $491.22 M(+52.1%) | $491.22 M(+28.2%) |
Sept 2011 | - | $383.23 M(+12.1%) |
June 2011 | - | $341.76 M(+9.3%) |
Mar 2011 | - | $312.57 M(-3.2%) |
Dec 2010 | $322.86 M(+9.8%) | $322.86 M(+2.3%) |
Sept 2010 | - | $315.64 M(+2.0%) |
June 2010 | - | $309.46 M(-5.4%) |
Mar 2010 | - | $327.15 M(+11.3%) |
Dec 2009 | $293.95 M(-10.2%) | $293.95 M(-6.8%) |
Sept 2009 | - | $315.25 M(-3.9%) |
June 2009 | - | $327.94 M(+1.0%) |
Mar 2009 | - | $324.68 M(-0.8%) |
Dec 2008 | $327.24 M(+24.0%) | $327.24 M(-4.1%) |
Sept 2008 | - | $341.37 M(+1.5%) |
June 2008 | - | $336.43 M(+11.0%) |
Mar 2008 | - | $303.22 M(+14.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2007 | $263.86 M(+76.3%) | $263.86 M(+3.8%) |
Sept 2007 | - | $254.09 M(-2.9%) |
June 2007 | - | $261.62 M(+11.6%) |
Mar 2007 | - | $234.41 M(+56.6%) |
Dec 2006 | $149.70 M(+23.3%) | $149.70 M(+9.0%) |
Sept 2006 | - | $137.39 M(-4.8%) |
June 2006 | - | $144.34 M(+28.9%) |
Mar 2006 | - | $112.00 M(-7.7%) |
Dec 2005 | $121.37 M(+4.5%) | $121.37 M(+8.8%) |
Sept 2005 | - | $111.50 M(+3.4%) |
June 2005 | - | $107.79 M(+7.3%) |
Mar 2005 | - | $100.47 M(-13.5%) |
Dec 2004 | $116.19 M(+7.0%) | $116.19 M(+12.6%) |
Sept 2004 | - | $103.20 M(+4.1%) |
June 2004 | - | $99.14 M(+3.1%) |
Mar 2004 | - | $96.14 M(-11.5%) |
Dec 2003 | $108.58 M(+42.0%) | $108.58 M(+15.3%) |
Sept 2003 | - | $94.16 M(+0.4%) |
June 2003 | - | $93.81 M(+12.3%) |
Mar 2003 | - | $83.57 M(+9.3%) |
Dec 2002 | $76.45 M(+7.1%) | $76.45 M(-16.1%) |
Sept 2002 | - | $91.12 M(+29.7%) |
June 2002 | - | $70.25 M(-13.4%) |
Mar 2002 | - | $81.10 M(+13.6%) |
Dec 2001 | $71.38 M(-3.6%) | $71.38 M(-3.6%) |
Sept 2001 | - | $74.02 M(+11.1%) |
June 2001 | - | $66.62 M(+1.8%) |
Mar 2001 | - | $65.44 M(-11.6%) |
Dec 2000 | $74.05 M(+0.5%) | $74.05 M(-15.8%) |
Sept 2000 | - | $87.96 M(+1.1%) |
June 2000 | - | $87.04 M(+19.2%) |
Mar 2000 | - | $72.99 M(-0.9%) |
Dec 1999 | $73.68 M(-6.4%) | $73.68 M(-1.0%) |
Sept 1999 | - | $74.40 M(-6.6%) |
June 1999 | - | $79.70 M(+14.2%) |
Mar 1999 | - | $69.80 M(-11.3%) |
Dec 1998 | $78.70 M(+5.9%) | $78.70 M(+34.8%) |
Sept 1998 | - | $58.40 M(-18.4%) |
June 1998 | - | $71.60 M(+3.8%) |
Mar 1998 | - | $69.00 M(-7.1%) |
Dec 1997 | $74.30 M(+45.1%) | $74.30 M(+6.1%) |
Sept 1997 | - | $70.00 M(+25.4%) |
June 1997 | - | $55.80 M(+13.2%) |
Mar 1997 | - | $49.30 M(-3.7%) |
Dec 1996 | $51.20 M(+53.3%) | $51.20 M(+7.8%) |
Sept 1996 | - | $47.50 M(-5.0%) |
June 1996 | - | $50.00 M(+39.7%) |
Mar 1996 | - | $35.80 M(+7.2%) |
Dec 1995 | $33.40 M(+52.5%) | $33.40 M(+4.7%) |
Sept 1995 | - | $31.90 M(-3.6%) |
June 1995 | - | $33.10 M(+8.9%) |
Mar 1995 | - | $30.40 M(+38.8%) |
Dec 1994 | $21.90 M(+52.1%) | $21.90 M(-2.7%) |
Sept 1994 | - | $22.50 M(-0.4%) |
June 1994 | - | $22.60 M(+18.3%) |
Mar 1994 | - | $19.10 M(+32.6%) |
Dec 1993 | $14.40 M(+54.8%) | $14.40 M(+2.9%) |
Sept 1993 | - | $14.00 M(+12.9%) |
June 1993 | - | $12.40 M(+9.7%) |
Mar 1993 | - | $11.30 M(+21.5%) |
Dec 1992 | $9.30 M(+40.9%) | $9.30 M(+2.2%) |
Sept 1992 | - | $9.10 M(-7.1%) |
June 1992 | - | $9.80 M(+4.3%) |
Mar 1992 | - | $9.40 M(+42.4%) |
Dec 1991 | $6.60 M | $6.60 M(0.0%) |
Sept 1991 | - | $6.60 M(-2.9%) |
June 1991 | - | $6.80 M |
FAQ
- What is IDEXX Laboratories annual total liabilities?
- What is the all time high annual total liabilities for IDEXX Laboratories?
- What is IDEXX Laboratories annual total liabilities year-on-year change?
- What is IDEXX Laboratories quarterly total liabilities?
- What is the all time high quarterly total liabilities for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly total liabilities year-on-year change?
What is IDEXX Laboratories annual total liabilities?
The current annual total liabilities of IDXX is $1.78 B
What is the all time high annual total liabilities for IDEXX Laboratories?
IDEXX Laboratories all-time high annual total liabilities is $2.14 B
What is IDEXX Laboratories annual total liabilities year-on-year change?
Over the past year, IDXX annual total liabilities has changed by -$362.63 M (-16.96%)
What is IDEXX Laboratories quarterly total liabilities?
The current quarterly total liabilities of IDXX is $1.73 B
What is the all time high quarterly total liabilities for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly total liabilities is $2.16 B
What is IDEXX Laboratories quarterly total liabilities year-on-year change?
Over the past year, IDXX quarterly total liabilities has changed by -$56.28 M (-3.15%)